The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Cryo-EM structures of tau filaments from Alzheimer’s disease
Open accessAbstract
Alzheimer's disease is the most common neurodegenerative disease, and there are no mechanism-based therapies. The disease is defined by the presence of abundant neurofibrillary lesions and neuritic plaques in the cerebral cortex. Neurofibrillary lesions comprise paired helical and straight tau filaments, whereas tau filaments with different morphologies characterize other neurodegenerative diseases. No high-resolution structures of tau filaments are available. Here we present cryo-electron microscopy (cryo-EM) maps at 3.4-3.5 Å resolution and corresponding atomic models of paired helical and straight filaments from the brain of an individual with Alzheimer's disease. Filament cores are made of two identical protofilaments comprising residues 306-378 of tau protein, which adopt a combined cross-β/β-helix structure and define the seed for tau aggregation. Paired helical and straight filaments differ in their inter-protofilament packing, showing that they are ultrastructural polymorphs. These findings demonstrate that cryo-EM allows atomic characterization of amyloid filaments from patient-derived material, and pave the way for investigation of a range of neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“ultra-structural analyses of tau filaments in brains from individuals with AD have shown that tau tangles contain both 3-repeat (3R)-tau and 4-repeat (4R)-tau isoforms (18)”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“In AD, tau tangles contain a mixture of 3R- and 4R-tau isoforms to adopt an AD-characteristic topology (18, 19).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“In AD, tau filaments assume a cross-β/β-helical fold (10).”
From MAP2 caps tau fibrils and inhibits aggregation (2023) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Misfolding and aberrant accumulation of Tau is a pathological hallmark of Alzheimer’s disease (AD)18, 19.”
From Multivalent cross-linking of actin filaments and microtubules through the microtubule-associated protein Tau (2017) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
Self-citationMolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E. J., Armache, J., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,496
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,497
Gctf: Real-time CTF determination and correction
Zhang, K. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.11.003 · Cited by 3,417
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Self-citationAtomic structures of amyloid cross-β spines reveal varied steric zippers
Sawaya, M. R., Sambashivan, S., Nelson, R. A., Ivanova, M. I., Sievers, S. A., Apostol, M. I., Thompson, M. J., Balbirnie, M., Wiltzius, J. J. W., McFarlane, H. T., et al. (2007) · Nature · doi:10.1038/nature05695 · Cited by 2,279
Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. Cohen
Sunde, M., Serpell, L. C., Bartlam, M. G., Fraser, P. E., Pepys, M. B., & Blake, C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1348 · Cited by 1,735
Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,003
Kametani, F., Yoshida, M., Matsubara, T., Murayama, S., Saito, Y., Kawakami, I., Onaya, M., Tanaka, H., Kakita, A., Robinson, A., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.581936 · Cited by 74
Microtubule associated proteins as targets for anticancer drug development
Khwaja, S., Kumar, K., Das, R., & Negi, A. S. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105320 · Cited by 76
Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
Boyarko, B., & HOOK, V. Y. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.702788 · Cited by 81
“Tau pathology manifests as the deposition of insoluble aggregated NFTs, fibrillar aggregates, neuropil threads, paired helical fragments (PHFs), and straight filaments (ST) resulting from hyperphosphorylation of normal tau which leads to decreased tau affinity to MT (Figure 2; Wischik et al., 1988; Perry et al., 1991;…”
BackgroundLiquid–Liquid Phase Separation of Tau Protein Is Encoded at the Monomeric Level
Dong, X., Bera, S., Qiao, Q., Tang, Y., Lao, Z., Luo, Y., Gazit, E., & Wei, G. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c00208 · Cited by 74
Lashuel, H. A. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.05.006 · Cited by 74
A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies
Imbimbo, B. P., Ippati, S., Watling, M., & Balducci, C. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12453 · Cited by 75
Protein nanofibrils and their use as building blocks of sustainable materials
Lendel, C., & Solin, N. (2021) · RSC Advances · doi:10.1039/d1ra06878d · Cited by 78
The Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02002-0 · Cited by 76
Cryo-EM: the resolution revolution and drug discovery
de Oliveira, T. M., van Beek, L., Shilliday, F., Debreczeni, J. É., & Phillips, C. (2021) · SLAS DISCOVERY · doi:10.1177/2472555220960401 · Cited by 73
Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application
Scapin, G., Potter, C. S., & Carragher, B. O. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.07.006 · Cited by 74
“For example, Baretić and coworkers (Baretić et al., 2017) report the structure of human ataxia telangiectasia mutated (ATM) protein, a large kinase involved in DNA repair and cancer: the protein is shown in two conformations (open and closed) and provides the first glimpse into the kinase structure; Fitzpatrick et al…”
BackgroundOrdered Assembly of Tau Protein and Neurodegeneration
Goedert, M., & Spillantini, M. G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_1 · Cited by 74
Self-citationArtificial Intracellular Filaments
Feng, Z., Wang, H., Wang, F., Oh, Y., Berciu, C., Cui, Q., Egelman, E. H., & Xu, B. (2020) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2020.100085 · Cited by 74
“Moreover, filaments of aberrant proteins are known to associate with human diseases,(5) such as tau filaments of Alzheimer diseases.(6)”
BackgroundStructure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
Dhavale, D. D., Barclay, A. M., Borcik, C. G., Basore, K., Berthold, D. A., Gordon, I. R., Liu, J., Milchberg, M. H., O’Shea, J. Y., Rau, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46832-5 · Cited by 72
Astrocyte senescence and SASP in neurodegeneration: tau joins the loop
Ungerleider, K., Beck, J. A., Lissa, D., Turnquist, C., Horikawa, I., Harris, B. T., & Harris, C. C. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1909260 · Cited by 72
“We decided to use a wild-type dGAE, a truncated core tau fragment (AA297391) found in AD paired helical filaments (PHF) [30,31,60] and containing the ordered sequences that have been resolved by cryo-EM in AD [52].”
MethodStructure of Tau filaments in Prion protein amyloidoses
Hallinan, G. I., Hoq, M. R., Ghosh, M., Vago, F. S., Fernández, A., Garringer, H. J., Vidal, R., Jiang, W., & Ghetti, B. F. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02336-w · Cited by 77
Self-citationPhage display derived peptides for Alzheimer's disease therapy and diagnosis
Zhang, X., Zhang, X., Gao, H., & Qing, G. (2022) · Theranostics · doi:10.7150/thno.68636 · Cited by 75
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
Tarutani, A., Adachi, T., Akatsu, H., Hashizume, Y., Hasegawa, K., Saito, Y., Robinson, A., Mann, D. M. A., Yoshida, M., Murayama, S., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02426-3 · Cited by 74
Structural mechanism for specific binding of chemical compounds to amyloid fibrils
Tao, Y., Xia, W., Zhao, Q., Xiang, H., Han, C., Zhang, S., Gu, W., Tang, W., Li, Y., Tan, L., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01370-x · Cited by 74
Melková, K., Zapletal, V., Narasimhan, S., Jansen, S., Hritz, J., Škrabana, R., Zweckstetter, M., Jensen, M. R., Blackledge, M. J., & Žídek, L. (2019) · Biomolecules · doi:10.3390/biom9030105 · Cited by 78
“Core structures of tau aggregates (paired helical filaments and straight filaments) reconstructed recently from cryo-EM images of samples isolated from brains of Alzheimer’s disease patients [24] show that the critical residues pack against Leu376 and His374 of filamentous tau40.”
BackgroundMethodCiccone, L., Shi, C., di Lorenzo, D., Van Baelen, A.-C., & Tonali, N. (2020) · Molecules · doi:10.3390/molecules25102439 · Cited by 69
Progression of Alzheimer’s disease, tau propagation, and its modifiable risk factors
Takeda, S. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.08.005 · Cited by 75
Santos, J., Pujols, J., Pallarès, I., Iglesias, V., & Ventura, S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.05.026 · Cited by 74
Gadhave, K., Kumar, D., Uversky, V. N., & Giri, R. (2020) · Medicinal Research Reviews · doi:10.1002/med.21719 · Cited by 71
“fibrillary lesions are abundantly found that consist of paired helical and straight tau filaments, whereas other tauopathies might contain tau filament with diverse morphologies.(125)”
BackgroundUltrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF
Hitt, B. D., Vaquer-Alicea, J., Manon, V. A., Beaver, J. D., Kashmer, O. M., Garcia, J. N., & Diamond, M. I. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01185-8 · Cited by 71
Cryo-EM structures of prion protein filaments from Gerstmann–Sträussler–Scheinker disease
Hallinan, G. I., Ozcan, K. A., Hoq, M. R., Cracco, L., Vago, F. S., Bharath, S. R., Li, D., Jacobsen, M. H., Doud, E. H., Mosley, A. L., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02461-0 · Cited by 71
“The filaments are made of three and four repeat (3R, 4R) Tau and the paired helical filaments (PHFs) are structurally identical to those extracted from the brains of AD patients [9, 18], an observation that suggests a common mechanism through which amyloids may trigger aggregation of Tau.”
BackgroundSelf-citationSeidler, P. M., Boyer, D. R., Murray, K. A., Yang, T. P., Bentzel, M., Sawaya, M. R., Rosenberg, G., Cascio, D., Williams, C. K., Newell, K. L., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009688 · Cited by 70
“For tau, this is exemplified by cryo-EM structures of patientderived fibrils from three different neurodegenerative diseases: two polymorphs from AD (10, 11), referred to as PHFs and SFs, which are ultrastructural polymorphs of each other, two from chronic traumatic encephalopathy (CTE) (12) and two from Pick’s diseas…”
BackgroundMethodInfluentialSelf-citationUnraveling the complexity of amyloid polymorphism using gold nanoparticles and cryo-EM
Cendrowska, U., Silva, P. J., Ait‐Bouziad, N., Müller, M., Güven, Z. P., Vieweg, S., Chiki, A., Radamaker, L., Kumar, S. T., Fändrich, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916176117 · Cited by 70
“This method is increasingly used to investigate the structure of amyloid fibrils prepared in vitro or derived from different tissues (11, 13, 31).”
BackgroundMethodInfluentialBamberger, C., Pankow, S., Martínez-Bartolomé, S., Ma, M., Diedrich, J., Rissman, R. A., & Yates, J. R. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00912 · Cited by 70
General Principles Underpinning Amyloid Structure
Taylor, A. I. P., & Staniforth, R. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.878869 · Cited by 72
Piper, S. J., Johnson, R. M., Wootten, D. L., & Sexton, P. M. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00837 · Cited by 78
Advanced Techniques for Detecting Protein Misfolding and Aggregation in Cellular Environments
Bai, Y., Zhang, S., Dong, H. Y., Liu, Y., Liu, C., & Zhang, X. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00494 · Cited by 72
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
Balusu, S., & Strooper, B. D. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02747-5 · Cited by 76
Oligomer Diversity during the Aggregation of the Repeat Region of Tau
Kjærgaard, M., Dear, A. J., Kundel, F., Qamar, S., Meisl, G., Knowles, T. P. J., & Klenerman, D. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00250 · Cited by 67
Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution
Ukmar, T., Fang, P., de Opakua, A. I., Henneberg, F., Godec, A., Pan, K., Cima‐Omori, M., Chari, A., Mandelkow�, E., Urlaub, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba3916 · Cited by 66
“The central part of the tau sequence is formed by pseudo-repeats, which bind to microtubules ( 8 , 9 ) and are essential for pathogenic aggregation and folding into cross- structure in tau amyloid fibrils ( 10 , 11 ).”
The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
Zubčić, K., Hof, P. R., Šimić, G., & Jembrek, M. J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.572308 · Cited by 71
Deng, R., Wu, H., Yan, W., & Mengdie, W. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113958 · Cited by 73
Tarutani, A., Lövestam, S., Zhang, X., Kotecha, A., Robinson, A., Mann, D. M. A., Saito, Y., Murayama, S., Tomita, T., Goedert, M., et al. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13657 · Cited by 70
Self-citationScialò, C., Cecco, E. D., Manganotti, P., & Legname, G. (2019) · Viruses · doi:10.3390/v11030261 · Cited by 69
“A high-resolution of AD-containing filaments were recently obtained from material purified from AD brains, confirming that the number of R regions deeply impacts fibrils formation and morphology [195].”
Backgroundd’Abramo, C., D'adamio, L., & Giliberto, L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030116 · Cited by 71
Islam, T., Hill, E., Abrahamson, E. E., Servaes, S., Smirnov, D. S., Zeng, X., Sehrawat, A., Chen, Y., Kac, P. R., Kvartsberg, H., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03400-0 · Cited by 76
“Advances in cryo-electron microscopy (cryo-EM) have enabled detailed biophysical characterization of tau filaments in NFTs 16,17 .”
Degradation or aggregation: the ramifications of post-translational modifications on tau
Park, S., Lee, J. H., Jeon, J. H., & Lee, M. J. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.6.077 · Cited by 73
Hsp40s play complementary roles in the prevention of tau amyloid formation
Irwin, R., Faust, O., Petrovic, I. M., Wolf, S. G., Hofmann, H., & Rosenzweig, R. (2021) · eLife · doi:10.7554/elife.69601 · Cited by 66
Proliferation of Tau 304–380 Fragment Aggregates through Autocatalytic Secondary Nucleation
Camargo, D. C. R., Šileikis, E., Chia, S., Axell, E., Bernfur, K., Cataldi, R., Cohen, S. I. A., Meisl, G., Habchi, J., Knowles, T. P. J., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00454 · Cited by 64
Viswanathan, G. K., Shwartz, D., Losev, Y., Arad, E., Shemesh, C., Pichinuk, E., Engel, H., Raveh, A., Jelinek, R., Cooper, I., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03312-0 · Cited by 67
Goedert, M., Crowther, R. A., Scheres, S. H. W., & Spillantini, M. G. (2023) · Cytoskeleton · doi:10.1002/cm.21812 · Cited by 64
“Cryo-EM structures of PHFs and SFs that were extracted from the frontal cortex of an individual with AD showed that each filament type comprises two identical protofilaments with a C-shaped ordered core, the Alzheimer tau fold (Fitzpatrick et al., 2017).”
BackgroundMethodSelf-citationThe prion-like propagation hypothesis in Alzheimer's and Parkinson's disease
Duyckaerts, C. J., Clavaguera, F., & Potier, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000672 · Cited by 71
Structural and molecular basis of cross-seeding barriers in amyloids
Daskalov, A., Martinez, D., Coustou, V., Mammeri, N. E., Berbon, M., Andreas, L. B., Bardiaux, B., Stanek, J., Noubhani, A., Kauffmann, B., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014085118 · Cited by 67
Wagner, T., Lusnig, L., Pospich, S., Stabrin, M., Schönfeld, F., & Raunser, S. (2020) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798320007342 · Cited by 64
NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice
Léger, P., Nachman, E., Richter, K., Tamietti, C., Koch, J., Burk, R., Kummer, S., Xin, Q., Stanifer, M. L., Bouloy, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17101-y · Cited by 62
Supramolecular Double Helices from Small C3-Symmetrical Molecules Aggregated in Water
Lafleur, R. P. M., Herziger, S., Schoenmakers, S. M. C., Keizer, A. D. A., Jahzerah, J., Thota, B. N. S., Su, L., Bomans, P. H. H., Sommerdijk, N. A. J. M., Palmans, A. R. A., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c08179 · Cited by 63
Molecular mechanisms of amyloid formation in living systems
Sinnige, T. (2022) · Chemical Science · doi:10.1039/d2sc01278b · Cited by 67
Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau
Schweighauser, M., Murzin, A. G., Macdonald, J. A., Lavenir, I., Crowther, R. A., Scheres, S. H. W., & Goedert, M. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01658-y · Cited by 69
“The structures of tau filaments from human brains comprise R3, R4 and 10–13 amino acids after R4 [24, 40, 41, 55, 56].”
BackgroundSelf-citationThe Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
Zheng, H., Sun, H., Cai, Q., & Tai, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094969 · Cited by 69
Insights into protein misfolding and aggregation enabled by solid-state NMR spectroscopy
van der Wel, P. C. A. (2017) · Solid State Nuclear Magnetic Resonance · doi:10.1016/j.ssnmr.2017.10.001 · Cited by 64
Tau-induced mitochondrial membrane perturbation is dependent upon cardiolipin
Camilleri, A., Ghio, S., Caruana, M., Weckbecker, D., Schmidt, F., Kamp, F., Leonov, A., Ryazanov, S., Griesinger, C., Giese, A., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.183064 · Cited by 66
FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
Kaniyappan, S., Tepper, K., Biernat, J., Chandupatla, R., Hübschmann, S., Irsen, S. H., Bicher, S., Klatt, C., Mandelkow, E., & Mandelkow�, E. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00389-1 · Cited by 65
“47 nm), similar to PHFs from AD brain [22].”
BackgroundResultInfluentialDirect measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation
Flagmeier, P., De, S., Michaels, T. C. T., Yang, X., Dear, A. J., Emanuelsson, C. S., Vendruscolo, M., Linse, S. S., Klenerman, D., Knowles, T. P. J., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0471-z · Cited by 63
Fichou, Y., Al‐Hilaly, Y. K., Devred, F., Smet‐Nocca, C., Tsvetkov, P. O., Verelst, J., Winderickx, J., Geukens, N., Vanmechelen, E., Perrotin, A., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0682-x · Cited by 67
Characterization of tau binding by gosuranemab
Sopko, R., Golonzhka, O., Arndt, J. W., Quan, C., Czerkowicz, J., Cameron, A., Smith, B., Yogapriya, M., Gibbons, G. S., Kim, S., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105120 · Cited by 65
Neutral Peptides in the Gas Phase: Conformation and Aggregation Issues
Gloaguen, E., Mons, M., Schwing, K., & Gerhards, M. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00168 · Cited by 63
Natural products for the treatment of neurodegenerative diseases
Cui, D., Chen, Y., Ye, B., Guo, W., Wang, D., & He, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155101 · Cited by 71
Karaboğa, M. N. S., & Sezgintürk, M. K. (2020) · Talanta · doi:10.1016/j.talanta.2020.121257 · Cited by 63
Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
Horie, K., Barthélemy, N. R., Mallipeddi, N., Li, Y., Franklin, E. E., Perrin, R. J., Bateman, R. J., & Sato, C. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01019-z · Cited by 62
Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease
Ossenkoppele, R., & Hansson, O. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12356 · Cited by 62
Fan, Y., Sun, Y., Yu, W., Tao, Y., Xia, W., Liu, Y., Zhao, Q., Tang, Y., Sun, Y., Liu, F., et al. (2022) · Structure · doi:10.1016/j.str.2022.11.013 · Cited by 67
Passive immunotherapy for Alzheimer's disease
Guo, X., Li, Y., Zhang, D., & Zhao, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102192 · Cited by 69
Han, Q., Wang, X., Cai, S., Liu, X., Zhang, Y., Yang, L., Wang, C., & Yang, R. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03053c · Cited by 62
Filamentous Aggregates Are Fragmented by the Proteasome Holoenzyme
Cliffe, R., Sang, J. C., Kundel, F., Finley, D. J., Klenerman, D., & Ye, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.096 · Cited by 62
“Error bars represent SD of measurements from the mean of three independent experiments (n = 3). stability (Fitzpatrick et al., 2017).”
BackgroundMembrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6
Fanni, A. M., Zanden, C. M. V., Majewska, P. V., Majewski, J. P., & Chi, E. Y. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010003 · Cited by 63
“The 24-Å thickness of the peptide layer under the monolayer was consistent with the PHF6 fibril structure (41) with one terminal lysine excluded from the measurement (Fig.”
BackgroundTau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
Oakley, S. S., Maina, M. B., Marshall, K. E., Al‐Hilaly, Y. K., Harrington, C., Wischik, C. M., & Serpell, L. C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590754 · Cited by 59
Cantrelle, F., Loyens, A., Trivelli, X., Reimann, O., Despres, C., Gandhi, N. S., Hackenberger, C. P. R., Landrieu, I., & Smet‐Nocca, C. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.661368 · Cited by 63
Tau and Membranes: Interactions That Promote Folding and Condensation
Sallaberry, C. A., Voss, B. J., Majewski, J. P., Biernat, J., Mandelkow�, E., Chi, E. Y., & Zanden, C. M. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725241 · Cited by 64
Stacked binding of a PET ligand to Alzheimer’s tau paired helical filaments
Merz, G. E., Chalkley, M. J., Tan, S. K., Tse, E., Lee, J., Prusiner, S. B., Paras, N. A., DeGrado, W. F., & Southworth, D. R. (2023) · Nature Communications · doi:10.1038/s41467-023-38537-y · Cited by 68
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Kunach, P., Vaquer‐Alicea, J., Smith, M. S., Monistrol, J., Hopewell, R., Moquin, L., Therriault, J., Tissot, C., Rahmouni, N., Massarweh, G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52265-x · Cited by 64
Mouchlis, V. D., Melagraki, G., Zacharia, L. C., & Afantitis, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030703 · Cited by 65
Ait‐Bouziad, N., Chiki, A., Limorenko, G., Xiao, S., Eliezer, D., & Lashuel, H. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012517 · Cited by 63
“The misfolding and aggregation of the microtubule (MT)- associated protein Tau have been linked to the pathogenesis of several neurodegenerative disorders (1), including Alzheimer disease (AD) (2), corticobasal degeneration (CBD) (3), progressive supranuclear palsy (3, 4), Pick’s disease, argyrophilic grain disease (5…”
Structural dynamics: review of time-resolved cryo-EM
Mäeots, M.-E., & Enchev, R. I. (2022) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798322006155 · Cited by 70
The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
Xu, Y., Uronen, R., & Huttunen, H. J. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.005 · Cited by 64
Segment from bank vole prion protein 168-176 QYNNQNNFV
Glynn, C. A., Rodriguez, J. A., Boyer, D. R., & Gallagher-Jones, M. (2017) · Worldwide Protein Data Bank · doi:10.2210/pdb6axz/pdb · Cited by 60
Li, Y., Wang, K., Zhou, K., Guo, W., Dai, B., Liang, Y., Dai, J., & Cui, M. (2018) · Chemical Communications · doi:10.1039/c8cc05259j · Cited by 59
Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau
Ferrari, L., Stucchi, R., Konstantoulea, K., van de Kamp, G., Kos, R., Geerts, W. J. C., van Bezouwen, L. S., Förster, F. G., Altelaar, M. A. F., Hoogenraad, C. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13745-7 · Cited by 65
Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease
Padmanabhan, P., Kneynsberg, A., & Götz, J. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00531-y · Cited by 59
Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
Huang, S., Wang, Y., & Guo, J. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00836-7 · Cited by 63
“Structural biology and the development of related techniques such as cryo-EM could help us to understand the microscopic structure of biomarkers in AD, such as Ab and tau[141, 142].”
BackgroundNeuronal identity defines α-synuclein and tau toxicity
Praschberger, R., Kuenen, S., Schoovaerts, N., Kaempf, N., Singh, J., Janssens, J., Swerts, J., Nachman, E., Calatayud, C., Aerts, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.033 · Cited by 66
Agüero, C., Dhaynaut, M., Amaral, A. C. S., Moon, S., Neelamegam, R., Scapellato, M., Carazo-Casas, C., Kumar, S., Fakhri, G. E., Johnson, K. A., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02672-z · Cited by 55
Despres, C., Di, J., Cantrelle, F., Li, Z., Huvent, I., Chambraud, B., Zhao, J., Chen, J., Chen, S., Lippens, G. M., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00325 · Cited by 61
Warmack, R. A., Boyer, D. R., Zee, C.-T., Richards, L. S., Sawaya, M. R., Cascio, D., Gonen, T., Eisenberg, D. S., & Clarke, S. G. (2019) · Nature Communications · doi:10.1038/s41467-019-11183-z · Cited by 59
Frontiers in Cryo Electron Microscopy of Complex Macromolecular Assemblies
Ognjenović, J., Grisshammer, R., & Subramaniam, S. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-060418-052453 · Cited by 63
Real-time observation of structure and dynamics during the liquid-to-solid transition of FUS LC
Berkeley, R. F., Kashefi, M., & Debelouchina, G. T. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.02.008 · Cited by 57
The AD tau core spontaneously self-assembles and recruits full-length tau to filaments
Carlomagno, Y., Manne, S., Deture, M. A., Prudencio, M., Zhang, Y., Al‐Shaikh, R. H., Dunmore, J. A., Daughrity, L. M., Song, Y., Castanedes‐Casey, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108843 · Cited by 59
Self-citationFluid biomarkers in Alzheimer's disease
Simrén, J., Elmgren, A., Blennow, K., & Zetterberg, H. (2023) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2022.09.006 · Cited by 58
Kang, J. H., Korecka, M., Lee, E. B., Cousins, K. A. Q., Tropea, T. F., Chen-Plotkin, A. A., Irwin, D. J., Wolk, D., Brylska, M., Wan, Y., et al. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad139 · Cited by 64
Lau, H. H. C., Ingelsson, M., & Watts, J. C. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02201-2 · Cited by 57
Glucose metabolism: A link between traumatic brain injury and Alzheimer’s disease
Xu, X., Yang, M.-S., Zhang, B., Niu, F., Dong, J., & Liu, B. (2020) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2020.10.001 · Cited by 59
Insight into the Structure of the “Unstructured” Tau Protein
Popov, K. I., Makepeace, K. A. T., Petrotchenko, E. V., Dokholyan, N. V., & Borchers, C. H. (2019) · Structure · doi:10.1016/j.str.2019.09.003 · Cited by 60
Structural basis for transthyretin amyloid formation in vitreous body of the eye
Iakovleva, I., Hall, M., Oelker, M., Sandblad, L., Anan, I., & Sauer-Eriksson, A. E. (2021) · Nature Communications · doi:10.1038/s41467-021-27481-4 · Cited by 57
KrishnaKumar, V. G., Paul, A., Gazit, E., & Segal, D. (2018) · Scientific Reports · doi:10.1038/s41598-017-18443-2 · Cited by 57
Lipid membrane templated misfolding and self-assembly of intrinsically disordered tau protein
Majewski, J. P., Jones, E. M., Zanden, C. M. V., Biernat, J., Mandelkow�, E., & Chi, E. Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-70208-6 · Cited by 56
Vitale, F., Giliberto, L., Ruiz, S., Steslow, K., Marambaud, P., & d’Abramo, C. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0585-2 · Cited by 59
Structural mapping of oligomeric intermediates in an amyloid assembly pathway
Karamanos, T. K., Jackson, M. P., Calabrese, A. N., Goodchild, S. C., Cawood, E. E., Thompson, G. S., Kalverda, A. P., Hewitt, E. W., & Radford, S. E. (2019) · eLife · doi:10.7554/elife.46574 · Cited by 57
Metadata
- Authors
- Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J., Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Indiana University Indianapolis (US)
- Corresponding author
- Goedert, Michel
- Scheres, Sjors H. W.
- ORCID
- Venue
- Nature
- Published
- 2017-07
- Volume
- 547
- Issue
- 7662
- Pages
- 185-190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5552202
- OpenAlex
- W2727929522
- Cited by
- 2,061
- References
- 58
- Citations by year
- 2026: 197 · 2025: 224 · 2024: 225 · 2023: 224 · 2022: 214 · 2021: 231 · 2020: 280 · 2019: 227 · 2018: 193 · 2017: 42
- FWCI
- 150.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- PMC
- Funders
- Medical Research Council (MC_EX_MR/N027892/1)
- National Institute on Aging (P30AG010133)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Advanced Electron Microscopy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, tau filaments, paired helical filaments, straight filaments, tau aggregation, protofilaments, tauopathy, neurodegenerative diseases
- MeSH terms
- Aged, Alzheimer Disease, Amino Acid Sequence, Amyloid, Brain, Female, Humans, tau Proteins, Cryoelectron Microscopy, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
